内容摘要：Andreas Tompros tours Ridgecrest Avocados in Somis, Calif., on Thursday, May 15, 2025. (AP Photo/Damian Dovarganes)

Andreas Tompros tours Ridgecrest Avocados in Somis, Calif., on Thursday, May 15, 2025. (AP Photo/Damian Dovarganes)

They hugged. “I thought Israel’s army had executed him,” he said.Palestinians also report being used as shields in the West Bank.

Palestinian Hazar Estity kisses her 21-month-old son, Nizar, who is being held by his grandmother, Nazek, on April 29, 2025, at an apartment in the West Bank town of Zababdeh. Estity says she was used as a human shield by Israeli soldiers. (AP Photo/Nasser Nasser)Palestinian Hazar Estity kisses her 21-month-old son, Nizar, who is being held by his grandmother, Nazek, on April 29, 2025, at an apartment in the West Bank town of Zababdeh. Estity says she was used as a human shield by Israeli soldiers. (AP Photo/Nasser Nasser)Hazar Estity said soldiers took her from her Jenin refugee camp home in November, forcing her to film inside several apartments and clear them before troops entered.

She said she pleaded to return to her 21-month-old son, but soldiers didn’t listen.“I was most afraid that they would kill me,” she said. “And that I wouldn’t see my son again.”

Magdy reported from Cairo.

NUSEIRAT, Franja de Gaza (AP) — El caos estalló nuevamente el jueves en la Franja de Gaza cuando decenas de miles de palestinos desesperados intentaron recoger alimentos de sitios de distribución administrados por una fundación respaldada por Estados Unidos e Israel. Múltiples testigos informaron de un descontrol de personas tomando ayuda, y dijeron que las tropas israelíes dispararon para controlar a las multitudes.The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other medical conditions that can cause cognitive difficulties. The Food and Drug Administration cleared it for patients 55 and older who are showing early signs of the disease.

More than 6 million people in the United States and millions more around the world have Alzheimer’s, the most common form of dementia.The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker for Alzheimer’s. Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans.

The lower costs and convenience of a blood test could also help expand use of two new drugs, Leqembi and Kisunla, which have been shown to slightly slow the progression of Alzheimer’s by clearing amyloid from the brain. Doctors are required to test patients for the plaque before prescribing the drugs, which require regular IV infusions.“Today’s clearance is an important step for Alzheimer’s disease diagnosis, making it easier and potentially more accessible for U.S. patients earlier in the disease,” said Dr. Michelle Tarver, of FDA’s center for devices.